A ditz at the Daily Beast calls Martin Shkreli “an Asshole” because he raised the price on a (pharmaceutical) product he owns by an allegedly exorbitant amount.
The dishonest Samantha Allen, along with other numerous oh-so-caring commie activists who jumped on the story, never mention that Shkreli paid a not piddling $55 million for the rights to Daraprim, and that the old price of $13.50 a tablet in a minuscule market for the drug makes that a very, very bad investment.
Now, surely, perhaps, Shkreli did make a very bad investment, and the Impax execs counted their lucky stars all the way to the bank, but that doesn’t make Shkreli an asshole. It only makes him an idiot.
AND it points up the flaws in the idiocy of the heavily regulated health/drug industry, as well as the direct idiocy of those who live to serve the idiocy of the heavily regulated health/drug industry.
The market for Daraprim is so small, and so tied up in governmental red tape, that a cheezer like Shkreli was willing to part with an exorbitant amount of good money for the chance of making a buck on a governmentally induced captive market. Only for it to happen that earnest types with no money or integrity of their own at stake have pulled the proverbial rug out from under him, with nothing but paltry disdain available to insure that a needed drug continues to be produced and made available to people who need it.
Shkreli isn’t going to get his $55 million back. At what point he decides to cut his losses (shutting down sales of Daraprim or selling the rights to some other fool) is anyone’s guess, but things don’t look good for those that need the drug.
Thanks to commies, and ignorant commie wannabe social justice warriors.
| M | T | W | T | F | S | S |
|---|---|---|---|---|---|---|
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 | 29 |
| 30 | ||||||